Evidence map›Paper›PMID 39493470›Full record

ReviewJournal of parasitic diseases : official organ of the Indian Society for Parasitology2024

To quest new targets of

Pratyusa Biswas, Rini Roy, Kuldip Ghosh, Debjani Nath, Asmita Samadder, Sisir Nandi

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of parasitic diseases : official organ of the Indian Society for Parasitology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Renaissance of farnesyltransferase inhibitors in cancer.Journal of translational medicine · 2026
    Review
  2. Antiplasmodial Activity of Methylangolensate FromJournal of tropical medicine · 2026
    Article
  3. In Silico Screening ofBiologics : targets & therapy · 2025
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pratyusa Biswas *Department of Zoology, University of Kalyani, Kalyani, Nadia 741235 India.
Rini Roy *Department of Zoology, University of Kalyani, Kalyani, Nadia 741235 India.
Kuldip GhoshDepartment of Zoology, University of Kalyani, Kalyani, Nadia 741235 India.
Debjani NathDepartment of Zoology, University of Kalyani, Kalyani, Nadia 741235 India.
Asmita SamadderDepartment of Zoology, University of Kalyani, Kalyani, Nadia 741235 India.
Sisir NandiDepartment of Pharmaceutical Chemistry, Global Institute of Pharmaceutical Education and Research (Affiliated to Veer Madho Singh Bhandari Uttarakhand Technical University), Kashipur, 244713 India.ORCID 0000-0002-9960-6584

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malaria remains a global health challenge with significant mortality and morbidity annually, with resistant parasite strains complicating treatment efforts. There is an acute need for novel antimalarial drugs that can put a stop to the future public health crisis caused by the multi-drug resistance strains of the

Indexed as

Dihydrofolate reductaseMalariaMulti-drug resistancePhosphatidyl inositol 4 kinasePlasmodium parasite

Identifiers

PMID39493470
PMCPMC11527868

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.